Literature DB >> 12204471

Physicochemical properties of quinolone antibiotics in various environments.

Hyoung-Ryun Park1, Tae Heung Kim, Ki-Min Bark.   

Abstract

The progress and photosensitivity of quinolone antibiotics are briefly described. By the photolysis of nalidixic acid, the loss of -COOH group is observed. The photoreaction of fluoroquinolones involves heterolytic C-F bond fragmentation. The protonation and divalent cation complexation equilibria are also examined. The spectroscopic properties of these drugs are intensively investigated in biological mimetic systems such as AOT reverse micelle, and H(2)O-CH(3)OH and H(2)O-CH(3)CN mixed solvents. For ofloxacin and norfloxacin, the excited-state intramolecular charge transfer (ICT) is observed. So, fluorescence spectra exhibit reverse solvatochromism in mixed solvents. The change of radiative and non-radiative rate constant can also be explained using this ICT. The influence of dielectric effects of solvent is more significant compared with the specific hydrogen bonding interaction. Theoretical treatments support all of these results.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12204471     DOI: 10.1016/s0223-5234(02)01361-2

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  20 in total

1.  Activity of the investigational fluoroquinolone finafloxacin against ciprofloxacin-sensitive and -resistant Acinetobacter baumannii isolates.

Authors:  Paul G Higgins; Will Stubbings; Hilmar Wisplinghoff; Harald Seifert
Journal:  Antimicrob Agents Chemother       Date:  2010-01-25       Impact factor: 5.191

2.  Residues of fluoroquinolones in marine aquaculture environment of the Pearl River Delta, South China.

Authors:  Xiuting He; Zhaohui Wang; Xiangping Nie; Yufen Yang; Debo Pan; Anna O W Leung; Zhang Cheng; Yongtao Yang; Kaibin Li; Kunci Chen
Journal:  Environ Geochem Health       Date:  2011-09-01       Impact factor: 4.609

3.  Spectroscopic and photophysical properties of protonated forms of some fluoroquinolones in solutions.

Authors:  A V Polishchuk; E T Karaseva; T B Emelina; V E Karasev
Journal:  J Fluoresc       Date:  2011-09-16       Impact factor: 2.217

4.  Design and synthesis of theranostic antibiotic nanodrugs that display enhanced antibacterial activity and luminescence.

Authors:  Sheng Xie; Sesha Manuguri; Giampiero Proietti; Joakim Romson; Ying Fu; A Ken Inge; Bin Wu; Yang Zhang; Daniel Häll; Olof Ramström; Mingdi Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-25       Impact factor: 11.205

5.  Photodegradation of fleroxacin injection: II. Kinetics and toxicological evaluation.

Authors:  Wei Li; Jun Wang; Yu-Zhu Hu
Journal:  AAPS PharmSciTech       Date:  2013-03-06       Impact factor: 3.246

6.  Removal of fluoroquinolone from aqueous solution using graphene oxide: experimental and computational elucidation.

Authors:  Sarita Yadav; Neetu Goel; Vinod Kumar; Kulbhushan Tikoo; Sonal Singhal
Journal:  Environ Sci Pollut Res Int       Date:  2017-11-16       Impact factor: 4.223

7.  Fluorescence quenching as a tool to investigate quinolone antibiotic interactions with bacterial protein OmpF.

Authors:  Patrícia Neves; Isabel Sousa; Mathias Winterhalter; Paula Gameiro
Journal:  J Membr Biol       Date:  2009-01-16       Impact factor: 1.843

8.  Interaction of the antibiotic norfloxacin with ionic micelles: pH-dependent binding.

Authors:  Gabriel Silva Vignoli Muniz; Letícia Regina Teixeira; Sonia Renaux Wanderley Louro
Journal:  Eur Biophys J       Date:  2014-08-05       Impact factor: 1.733

9.  Effects of norfloxacin and butylated hydroxyanisole on the freshwater microalga Scenedesmus obliquus.

Authors:  Xiangping Nie; Jiguang Gu; Jinyan Lu; Weibing Pan; Yufen Yang
Journal:  Ecotoxicology       Date:  2009-06-04       Impact factor: 2.823

10.  Involvement of reactive oxygen species in the action of ciprofloxacin against Escherichia coli.

Authors:  M Goswami; S H Mangoli; N Jawali
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.